Aripiprazole is indicated for treating symptoms of schizophrenia, bipolar disorder, and major depressive disorder.
Unipharm’s generic Aripiprazole Tablets have been manufactured and marketed in Israel since 2012.
Strengths: 5, 10, 15 & 30 mg
Dosage form: Tablets
Out-licensing is offered for all international markets*
Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect